These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32739429)

  • 1. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
    Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
    Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGG1 regulates the level of symmetric dimethylation of histone H4 arginine-3 by interacting with PRMT5.
    Zhou X; Wang W; Du C; Yan F; Yang S; He K; Wang H; Zhao A
    Mol Cell Probes; 2018 Apr; 38():19-24. PubMed ID: 29409673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cardiomyocyte hypertrophy by protein arginine methyltransferase 5.
    Chen M; Yi B; Sun J
    J Biol Chem; 2014 Aug; 289(35):24325-35. PubMed ID: 25012667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KSHV encoded ORF59 modulates histone arginine methylation of the viral genome to promote viral reactivation.
    Strahan RC; McDowell-Sargent M; Uppal T; Purushothaman P; Verma SC
    PLoS Pathog; 2017 Jul; 13(7):e1006482. PubMed ID: 28678843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.
    Zhao Q; Rank G; Tan YT; Li H; Moritz RL; Simpson RJ; Cerruti L; Curtis DJ; Patel DJ; Allis CD; Cunningham JM; Jane SM
    Nat Struct Mol Biol; 2009 Mar; 16(3):304-311. PubMed ID: 19234465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
    Shailesh H; Siveen KS; Sif S
    J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cells.
    Mongiardi MP; Savino M; Bartoli L; Beji S; Nanni S; Scagnoli F; Falchetti ML; Favia A; Farsetti A; Levi A; Nasi S; Illi B
    Sci Rep; 2015 Nov; 5():15494. PubMed ID: 26563484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
    Saha K; Adhikary G; Eckert RL
    J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
    Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
    Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G + C-rich regions of the mouse genome.
    Girardot M; Hirasawa R; Kacem S; Fritsch L; Pontis J; Kota SK; Filipponi D; Fabbrizio E; Sardet C; Lohmann F; Kadam S; Ait-Si-Ali S; Feil R
    Nucleic Acids Res; 2014 Jan; 42(1):235-48. PubMed ID: 24097435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-synuclein promotes PRMT5-mediated H4R3me2s histone methylation by interacting with the BAF complex.
    Nakamura T; Sugeno N; Hasegawa T; Ikeda K; Yoshida S; Ishiyama S; Sato K; Takeda A; Aoki M
    FEBS J; 2024 May; 291(9):1892-1908. PubMed ID: 38105619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.
    Chung J; Karkhanis V; Baiocchi RA; Sif S
    J Biol Chem; 2019 May; 294(19):7692-7710. PubMed ID: 30885941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N
    Gao XQ; Zhang YH; Liu F; Ponnusamy M; Zhao XM; Zhou LY; Zhai M; Liu CY; Li XM; Wang M; Shan C; Shan PP; Wang Y; Dong YH; Qian LL; Yu T; Ju J; Wang T; Wang K; Chen XZ; Wang YH; Zhang J; Li PF; Wang K
    Nat Cell Biol; 2020 Nov; 22(11):1319-1331. PubMed ID: 33020597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
    J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression.
    Cai S; Liu R; Wang P; Li J; Xie T; Wang M; Cao Y; Li Z; Liu P
    Front Pharmacol; 2020; 11():600627. PubMed ID: 33424610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT5-dependent transcriptional repression of c-Myc target genes promotes gastric cancer progression.
    Liu M; Yao B; Gui T; Guo C; Wu X; Li J; Ma L; Deng Y; Xu P; Wang Y; Yang D; Li Q; Zeng X; Li X; Hu R; Ge J; Yu Z; Chen Y; Chen B; Ju J; Zhao Q
    Theranostics; 2020; 10(10):4437-4452. PubMed ID: 32292506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of substrate modifications on the arginine dimethylation activities of PRMT1 and PRMT5.
    Fulton MD; Dang T; Brown T; Zheng YG
    Epigenetics; 2022 Jan; 17(1):1-18. PubMed ID: 33380261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.